There have been a number of new regulatory developments over the past few months that potentially impact CLO transactions. The Maples Group is proactively monitoring and addressing these regulatory developments to ensure that client CLO transactions are compliant with new requirements. This CLOser Look focuses on the implications of the recent regulatory developments on the CLO market in particular, and provides links to the more general updates that have been issued by the Maples Group.

Print Ready Version.

CONTACTS

bioImage

Scott Macdonald

Partner

+1 345 814 5317

bioImage

John Dykstra

Partner

+1 345 814 5530

bioImage

Stephen McLoughlin

Partner

+353 1 619 2736

bioImage

James Lawler

Senior Vice President

+1 302 340 9985

*
*
*
*


Please note that your email may be received and read by other Maples Group employees in addition to your intended recipient.

The use of this form does not create an attorney-client relationship and information submitted will not necessarily be treated as privileged or confidential, nor will it prevent us from accepting related instructions on behalf of others. Do not send us any information regarding any current or potential legal matters until your proposed engagement of us as legal counsel has been agreed and confirmed by us in writing.

*
*
*

Please note that your email may be received and read by other Maples Group employees in addition to your intended recipient.

Connect

Want to get in touch ?

Contact Us